Differential Expression of Serum Exosomal miRNAs in Breast Cancer Patients and Healthy Controls

被引:6
|
作者
Asgari, Rahim [1 ]
Rezaie, Jafar [1 ]
机构
[1] Urmia Univ Med Sci, Cellular & Mol Med Inst, Solid Tumor Res Ctr, Orumiyeh, Iran
关键词
Breast cancer; Exosomes; miRs; Biomarker; MICRORNAS; BIOMARKER; INVASION; MIR-21;
D O I
10.34172/apb.2022.088
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose: Breast cancer has become as a serious public health concern worldwide. Breast cancer cells release exosomes into the circulatory system, which are easily accessible for further analysis like cancer diagnosis. In this study, we aimed to investigate expression of circulating exosomal miRNAs (miRs) in the serum of individuals with breast cancer and healthy controls. Methods: Exosomes were collected from serum samples using a commercial kit and characterized by scanning electron microscopy (SEM) and flow cytometry analysis. Expression of miRs such as miR-21, miR-155, miR-182, miR-373, and miR-126 were evaluated by real-time PCR. Results: The result showed that the expression level of exosomal miR-21, miR-155, miR182, and miR-373 in the serum of breast cancer patients was higher than of those controls (P<0.05). However, expression of miR-126 did not change between breast cancer and control individuals (P> 0.05). Conclusion: Our results showed a different miRs expression pattern between breast cancer and healthy samples, supposing potential biomarkers for breast cancer. Further studies focusing on these miRs are required to confirm our findings.
引用
收藏
页码:858 / 862
页数:5
相关论文
共 50 条
  • [31] Exosomal miRNAs as Next-generation Therapy Vehicles in Breast Cancer
    Thakur, Priyanka
    Dahiya, Harshita
    Kaushal, Ankur
    Gupta, Vijai Kumar
    Saini, Adesh K.
    Saini, Reena V.
    CURRENT GENE THERAPY, 2023, 23 (05) : 330 - 342
  • [32] Circular RNA expression in exosomes derived from breast cancer cells and patients
    Wang, Jinyan
    Zhang, Qian
    Zhou, Siying
    Xu, Hanzi
    Wang, Dandan
    Feng, Jifeng
    Zhao, Jianhua
    Zhong, Shanliang
    EPIGENOMICS, 2019, 11 (04) : 411 - 421
  • [33] Exploration of Exosomal miRNAs from Serum and Synovial Fluid in Arthritis Patients
    Xie, Yingying
    Chen, Wenwen
    Zhao, Mengqian
    Xu, Yuhai
    Yu, Hao
    Qin, Jianhua
    Li, Hongjing
    DIAGNOSTICS, 2022, 12 (02)
  • [34] Over-expression of mir-181a-3p in serum of breast cancer patients as diagnostic biomarker
    Fouladi, Hadi
    Ebrahimi, Amir
    Derakhshan, Sima Mansoori
    Khaniani, Mahmoud Shekari
    MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
  • [35] Clinical importance of serum miRNA levels in breast cancer patients
    Turkoglu, Fatih
    Calisir, Akin
    Ozturk, Bahadir
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [36] SERUM FERRITIN IN HEALTHY WOMEN AND BREAST CANCER PATIENTS
    Cujic, Danica
    Stefanoska, Ivana
    Golubovic, Snezana
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2011, 30 (01) : 33 - 37
  • [37] Serum expression of selected miRNAs in patients with laryngeal squamous cell carcinoma (LSCC)
    Grzelczyk, Weronika Lucas
    Szemraj, Janusz
    Kwiatkowska, Sylwia
    Jozefowicz-Korczynska, Magdalena
    DIAGNOSTIC PATHOLOGY, 2019, 14 (1)
  • [38] Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach
    Boehm, Daniel
    Keller, Ksenia
    Pieter, Julia
    Boehm, Nils
    Wolters, Dominik
    Siggelkow, Wulf
    Lebrecht, Antje
    Schmidt, Marcus
    Koelbl, Heinz
    Pfeiffer, Norbert
    Grus, Franz-Hermann
    ONCOLOGY REPORTS, 2012, 28 (02) : 429 - 438
  • [39] Clinical Relevance of Circulating, Cell-Free and Exosomal microRNAs in Plasma and Serum of Breast Cancer Patients
    Schwarzenbach, Heidi
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (7-8) : 423 - 429
  • [40] Exosomal prognostic biomarkers predict metastatic progression and survival in breast cancer patients
    Serdar, Ceyhan Ceran
    Osmanlioglu, Seyma
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2023, 48 (05): : 541 - 562